HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H Michael Shepard Selected Research
H Michael Shepard Research Topics
Disease
22
Neoplasms (Cancer)
01/2021 - 04/2002
4
Breast Neoplasms (Breast Cancer)
11/2019 - 04/2002
3
Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 01/2014
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 01/2009
3
Arthritis (Polyarthritis)
01/2011 - 01/2008
2
Multiple Sclerosis
01/2023 - 12/2018
2
Hypoxia (Hypoxemia)
10/2018 - 01/2014
2
Adenocarcinoma
01/2016 - 08/2015
2
Experimental Arthritis
01/2011 - 10/2008
1
Demyelinating Diseases (Demyelinating Disease)
01/2023
1
Autoimmune Diseases (Autoimmune Disease)
01/2023
1
Neoplasm Metastasis (Metastasis)
08/2015
1
Fibrosis (Cirrhosis)
08/2015
1
Squamous Cell Carcinoma of Head and Neck
02/2015
1
Inflammation (Inflammations)
06/2014
1
Necrosis
01/2011
1
Hyperplasia
01/2008
1
Rheumatoid Arthritis
01/2008
1
Colonic Neoplasms (Colon Cancer)
04/2002
1
Carcinoma (Carcinomatosis)
04/2002
Drug/Important Bio-Agent (IBA)
11
Hyaluronic Acid (Hyaluronan)
IBA
11/2019 - 11/2010
9
PEGPH20
IBA
11/2019 - 11/2010
8
Hyaluronoglucosaminidase (Hyaluronidase)
FDA Link
11/2019 - 09/2012
5
ErbB Receptors (EGF Receptor)
IBA
01/2011 - 10/2008
4
Glycosaminoglycans
IBA
01/2014 - 11/2010
4
Proteins (Proteins, Gene)
FDA Link
01/2014 - 04/2002
4
Ligands
IBA
01/2011 - 01/2008
3
Enzymes
IBA
01/2021 - 04/2002
3
Trastuzumab (Herceptin)
FDA Link
10/2019 - 01/2011
3
Monoclonal Antibodies
IBA
06/2017 - 11/2008
3
Epidermal Growth Factor (EGF)
IBA
01/2011 - 10/2008
2
Chimeric Antigen Receptors
IBA
12/2019 - 11/2019
2
Antigens
IBA
12/2019 - 11/2019
2
Hyaluronan Synthases
IBA
11/2019 - 01/2014
2
Collagen
IBA
10/2018 - 08/2015
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2015 - 01/2008
1
Autoantigens
IBA
01/2023
1
Deoxycytidine Kinase
IBA
01/2023
1
Adenosine Deaminase
IBA
01/2021
1
Adenosine (Adenocard)
FDA Link
Generic
01/2021
1
Small Interfering RNA (siRNA)
IBA
11/2019
1
Glycopeptides
IBA
11/2019
1
Biomarkers (Surrogate Marker)
IBA
10/2019
1
Cytokines
IBA
10/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2018
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
10/2018
1
Gemcitabine
FDA Link
01/2016
1
Cetuximab (Erbitux)
FDA Link
02/2015
1
Carrier Proteins (Binding Protein)
IBA
01/2015
1
Endotoxins
IBA
06/2014
1
Lipopolysaccharides
IBA
06/2014
1
Cadherins (E-Cadherin)
IBA
01/2014
1
Catenins
IBA
01/2014
1
Etanercept (Enbrel)
FDA Link
01/2011
1
Colloids (Colloid)
IBA
11/2010
1
liposomal doxorubicin (Doxil)
FDA Link
11/2010
1
Polymers
IBA
11/2010
1
Proteoglycans (Proteoglycan)
IBA
11/2010
1
Docetaxel (Taxotere)
FDA Link
11/2010
1
Sequestering Agents
IBA
01/2009
1
Tyrosine Kinase Inhibitors
IBA
10/2008
1
lysophosphatidic acid
IBA
10/2008
1
Tyrosine (L-Tyrosine)
FDA Link
10/2008
1
herstatin
IBA
10/2008
1
Cell Surface Receptors
IBA
01/2008
1
Messenger RNA (mRNA)
IBA
01/2008
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2008
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
01/2008
1
NB1011
IBA
04/2002
1
Irinotecan (Camptosar)
FDA Link
Generic
04/2002
1
Thymidylate Synthase
IBA
04/2002
1
raltitrexed (D 1694)
IBA
04/2002
1
DNA (Deoxyribonucleic Acid)
IBA
04/2002
Therapy/Procedure
11
Therapeutics
01/2021 - 01/2008
2
Immunotherapy
01/2021 - 02/2015
2
Drug Therapy (Chemotherapy)
09/2012 - 11/2010
1
Biological Therapy
01/2008